FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3204195032> ?p ?o ?g. }

• W3204195032 endingPage "575" @default.
• W3204195032 startingPage "569" @default.
• W3204195032 abstract "Albumin-bilirubin (ALBI) grade is an objective measure of liver function for patients with hepatocellular carcinoma (HCC). The tyrosine kinase inhibitor cabozantinib is approved for patients with advanced HCC who have received prior sorafenib based on the phase 3 CELESTIAL trial (NCT01908426). Cabozantinib improved overall survival (OS) and progression-free survival (PFS) versus placebo in patients with previously treated HCC.Patients were randomised 2:1 to receive cabozantinib 60 mg or placebo orally every day. Clinical outcomes in patients with ALBI grade 1 or 2 at baseline were evaluated in CELESTIAL. ALBI scores were retrospectively calculated based on baseline serum albumin and total bilirubin, with an ALBI grade of 1 defined as ≤ -2.60 score and a grade of 2 as a score of > -2.60 to ≤ -1.39.Cabozantinib improved OS and PFS versus placebo in both ALBI grade 1 (hazard ratio [HR] [95% CI]: 0.63 [0.46-0.86] and 0.42 [0.32-0.56]) and ALBI grade 2 (HR [95% CI]: 0.84 [0.66-1.06] and 0.46 [0.37-0.58]) subgroups. Adverse events were consistent with those in the overall population. Rates of grade 3/4 adverse events associated with hepatic decompensation were generally low and were more common among patients in the ALBI grade 2 subgroup.These results provide initial support of cabozantinib in patients with advanced HCC irrespective of ALBI grade 1 or 2.ClinicalTrials.gov number, NCT01908426." @default.
• W3204195032 created "2021-10-11" @default.
• W3204195032 creator A5013744957 @default.
• W3204195032 creator A5019481117 @default.
• W3204195032 creator A5024642006 @default.
• W3204195032 creator A5029171331 @default.
• W3204195032 creator A5035601295 @default.
• W3204195032 creator A5037186906 @default.
• W3204195032 creator A5042306519 @default.
• W3204195032 creator A5052741985 @default.
• W3204195032 creator A5059267212 @default.
• W3204195032 creator A5059941445 @default.
• W3204195032 creator A5060350068 @default.
• W3204195032 creator A5064570128 @default.
• W3204195032 creator A5067784766 @default.
• W3204195032 creator A5081273660 @default.
• W3204195032 date "2021-10-07" @default.
• W3204195032 modified "2023-10-17" @default.
• W3204195032 title "Efficacy and safety of cabozantinib for patients with advanced hepatocellular carcinoma based on albumin-bilirubin grade" @default.
• W3204195032 cites W2100945326 @default.
• W3204195032 cites W2119190881 @default.
• W3204195032 cites W2396589869 @default.
• W3204195032 cites W2582878252 @default.
• W3204195032 cites W2776090439 @default.
• W3204195032 cites W2796067155 @default.
• W3204195032 cites W2809889937 @default.
• W3204195032 cites W3040740064 @default.
• W3204195032 cites W3110333352 @default.
• W3204195032 cites W4292405063 @default.
• W3204195032 doi "https://doi.org/10.1038/s41416-021-01532-5" @default.
• W3204195032 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34621044" @default.
• W3204195032 hasPublicationYear "2021" @default.
• W3204195032 type Work @default.
• W3204195032 sameAs 3204195032 @default.
• W3204195032 citedByCount "10" @default.
• W3204195032 countsByYear W32041950322021 @default.
• W3204195032 countsByYear W32041950322022 @default.
• W3204195032 countsByYear W32041950322023 @default.
• W3204195032 crossrefType "journal-article" @default.
• W3204195032 hasAuthorship W3204195032A5013744957 @default.
• W3204195032 hasAuthorship W3204195032A5019481117 @default.
• W3204195032 hasAuthorship W3204195032A5024642006 @default.
• W3204195032 hasAuthorship W3204195032A5029171331 @default.
• W3204195032 hasAuthorship W3204195032A5035601295 @default.
• W3204195032 hasAuthorship W3204195032A5037186906 @default.
• W3204195032 hasAuthorship W3204195032A5042306519 @default.
• W3204195032 hasAuthorship W3204195032A5052741985 @default.
• W3204195032 hasAuthorship W3204195032A5059267212 @default.
• W3204195032 hasAuthorship W3204195032A5059941445 @default.
• W3204195032 hasAuthorship W3204195032A5060350068 @default.
• W3204195032 hasAuthorship W3204195032A5064570128 @default.
• W3204195032 hasAuthorship W3204195032A5067784766 @default.
• W3204195032 hasAuthorship W3204195032A5081273660 @default.
• W3204195032 hasBestOaLocation W32041950321 @default.
• W3204195032 hasConcept C121608353 @default.
• W3204195032 hasConcept C126322002 @default.
• W3204195032 hasConcept C142724271 @default.
• W3204195032 hasConcept C143998085 @default.
• W3204195032 hasConcept C197934379 @default.
• W3204195032 hasConcept C204787440 @default.
• W3204195032 hasConcept C207103383 @default.
• W3204195032 hasConcept C27081682 @default.
• W3204195032 hasConcept C2776539811 @default.
• W3204195032 hasConcept C2777513400 @default.
• W3204195032 hasConcept C2778019345 @default.
• W3204195032 hasConcept C2778695046 @default.
• W3204195032 hasConcept C2781064419 @default.
• W3204195032 hasConcept C2908647359 @default.
• W3204195032 hasConcept C2992208098 @default.
• W3204195032 hasConcept C44249647 @default.
• W3204195032 hasConcept C71924100 @default.
• W3204195032 hasConcept C90924648 @default.
• W3204195032 hasConcept C99454951 @default.
• W3204195032 hasConceptScore W3204195032C121608353 @default.
• W3204195032 hasConceptScore W3204195032C126322002 @default.
• W3204195032 hasConceptScore W3204195032C142724271 @default.
• W3204195032 hasConceptScore W3204195032C143998085 @default.
• W3204195032 hasConceptScore W3204195032C197934379 @default.
• W3204195032 hasConceptScore W3204195032C204787440 @default.
• W3204195032 hasConceptScore W3204195032C207103383 @default.
• W3204195032 hasConceptScore W3204195032C27081682 @default.
• W3204195032 hasConceptScore W3204195032C2776539811 @default.
• W3204195032 hasConceptScore W3204195032C2777513400 @default.
• W3204195032 hasConceptScore W3204195032C2778019345 @default.
• W3204195032 hasConceptScore W3204195032C2778695046 @default.
• W3204195032 hasConceptScore W3204195032C2781064419 @default.
• W3204195032 hasConceptScore W3204195032C2908647359 @default.
• W3204195032 hasConceptScore W3204195032C2992208098 @default.
• W3204195032 hasConceptScore W3204195032C44249647 @default.
• W3204195032 hasConceptScore W3204195032C71924100 @default.
• W3204195032 hasConceptScore W3204195032C90924648 @default.
• W3204195032 hasConceptScore W3204195032C99454951 @default.
• W3204195032 hasFunder F4320312140 @default.
• W3204195032 hasIssue "4" @default.
• W3204195032 hasLocation W32041950321 @default.
• W3204195032 hasLocation W32041950322 @default.
• W3204195032 hasLocation W32041950323 @default.
• W3204195032 hasLocation W32041950324 @default.

• next